Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic

Japanese Journal of Clinical Oncology

Volumn 44, Issue 2, 2014, Pages 168-171

  Sakaida, Emiko ^a   Sekine, Ikuo ^a   Iwasawa, Shunichiro ^a   Kurimoto, Ryota ^a   Uehara, Takashi ^a   Ooka, Yoshihiko ^a   Akanuma, Naoki ^a   Tada, Yuji ^a   Imai, Chiaki ^b   Oku, Tomoko ^b   Takiguchi, Yuichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chemotherapy; Cytotoxic agents; Extravasation; Outpatient

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOCETAXEL; IRINOTECAN; NAVELBINE; PACLITAXEL; VINCRISTINE;

ADULT; AGED; APPLICATION SITE BURNING; APPLICATION SITE PAIN; ARTICLE; BILE DUCT CARCINOMA; BREAST CANCER; BURNING SENSATION; CANCER CHEMOTHERAPY; CLINICAL FEATURE; COLORECTAL CANCER; DISEASE SEVERITY; DRUG EXTRAVASATION; EXTRAVASATION; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; OVARY CANCER; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH CANCER; TREATMENT OUTCOME; UTERUS CANCER; VERY ELDERLY; WALKING;

CHEMOTHERAPY; CYTOTOXIC AGENTS; EXTRAVASATION; OUTPATIENT;

ADULT; AGED; AMBULATORY CARE FACILITIES; ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT CARE TEAM; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84893557261     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt186     Document Type: Article

References (8)

1. Schulmeister L. Extravasation management: clinical update. Semin Oncol Nurs 2011;27:82-90.
2. Adami NP, de Gutierrez MG, da Fonseca SM, de Almeida EP. Risk management of extravasation of cytostatic drugs at the adult chemotherapy outpatient clinic of a university hospital. J Clin Nurs 2005;14:876-82.
3. Ener RA, Meglathery SB, Styler M. Extravasation of systemic hemato-oncological therapies. Ann Oncol 2004;15:858-62.
4. Langstein HN, Duman H, Seelig D, Butler CE, Evans GR. Retrospective study of the management of chemotherapeutic extravasation injury. Ann Plast Surg 2002;49:369-74.
5. Khan MS, Holmes JD. Reducing the morbidity from extravasation injuries. Ann Plast Surg 2002;48:628-32.
6. Barlock AL, Howser DM, Hubbard SM. Nursing management of adriamycin extravasation. Am J Nurs 1979;79:94-6.
7. Wengstrom Y, Margulies A. European Oncology Nursing Society extravasation guidelines. Eur J Oncol Nurs 2008;12:357-61.
8. Kurul S, Saip P, Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 2002;3:684-92.